Submit Deal

Optimum Strategic Communications

Summary

Optimum is an international strategic communications firm specialising in investor relations, corporate and financial communications

Market Context

Deals Overview

Edit Data

Total Deals16

Valued Deals15

Total Value£ 5.85 B

Avg. Deal Size£ 390 M

11 Dec 2024|Switzerland|Biotechnology

Target: NOEMA PHARMA

Bidder: EQT LIFE SCIENCES

5 Service Providers

4 Target | 1 Bidder

11 Dealmakers

10 Target | 1 Bidder

£ 24 M

Value

29 May 2024|Denmark|Biotechnology

Target: ADCENDO APS

Bidder: DAWN BIOPHARMA

4 Service Providers

3 Target | 1 Bidder

7 Dealmakers

6 Target | 1 Bidder

£ 13 M

Value

04 Apr 2023|Denmark|Biotechnology

Target: ADCENDO APS

Bidder: PONTIFAX VENTURE CAPITAL

4 Service Providers

3 Target | 1 Bidder

8 Dealmakers

7 Target | 1 Bidder

£ 33 M

Value

03 Oct 2022|United States|Pharmaceuticals

Target: VILLARIS THERAPEUTICS

Bidder: INCYTE CORPORATION

5 Service Providers

3 Target | 2 Bidder

19 Dealmakers

13 Target | 6 Bidder

£ 340 M

Value

16 May 2022|France|Private Equity

Target: SOFINNOVA PARTNERS

Bidder: APOLLO GLOBAL MANAGEMENT INC

12 Service Providers

4 Target | 8 Bidder

24 Dealmakers

13 Target | 11 Bidder

£ 849 M

Value

03 May 2022|Switzerland|Online and Social Platforms

Target: ENGIMMUNE THERAPEUTICS AG

Bidder: NOVO HOLDINGS A/S

6 Service Providers

1 Target | 5 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 12 M

Value

22 Feb 2022|Netherlands|Biotechnology

Target: TARGED BIOPHARMACEUTICALS

Bidder: UTRECHT HEALTH SEED FUND

10 Service Providers

3 Target | 7 Bidder

21 Dealmakers

8 Target | 13 Bidder

£ 32 M

Value

11 May 2021|Germany|Biotechnology

Target: AMSILK

Bidder: MIG VERWALTUNGS AG

7 Service Providers

1 Target | 6 Bidder

16 Dealmakers

3 Target | 13 Bidder

£ 25 M

Value

16 Feb 2021|United Kingdom|Pharmaceuticals

Target: CENTESSA PHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

20 Service Providers

5 Target | 15 Bidder

27 Dealmakers

9 Target | 19 Bidder

£ 179 M

Value

10 Dec 2020|Switzerland|Biotechnology

Target: NBE THERAPEUTICS

Bidder: BOEHRINGER INGELHEIM GMBH

8 Service Providers

3 Target | 2 Bidder | 3 Vendor

12 Dealmakers

4 Target | 3 Bidder | 5 Vendor

£ 1.07 B

Value

05 Nov 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

02 Nov 2020|Netherlands|Biotechnology

Target: KIADIS PHARMA NV

Bidder: SANOFI SA

9 Service Providers

5 Target | 3 Bidder | 1 Vendor

37 Dealmakers

8 Target | 28 Bidder | 1 Vendor

£ 276 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy